Announcing Trialbee Honey ™, the Smarter Platform to Enable Patient Recruitment Teams to Accelerate Enrollment Times

Unique technology enables real-time analytics to track, measure and analyze all patient enrollment activity, from outreach to randomization

MALMO, Sweden, October 26, 2021– (COMMERCIAL THREAD) –test bee, Leader in Technology-Based Patient Matching and Enrollment, Launches Trialbee Honey Software Platform, the First Solution to Provide Tracking and Measurement of All Recruitment Activity, Regardless of Referral Sources . Honey was designed for patient recruitment teams to recruit and engage highly qualified patients while optimizing enrollment times through real-time analytics. With 50,000 expected clinical trials requiring 125 million patients over the next five years, patient recruitment faced increased pressure to meet registration deadlines.

Trialbee Honey’s data and information-driven solution is uniquely designed for the next era of clinical research. The platform enables sites, sponsors and CROs to ensure timely patient recruitment results in support of trial objectives.

“Trialbee aims to crack the code of patient recruitment with disruptive software products that optimize the patient experience, reduce site load, and enable sponsors and CROs to gain data-driven insights into their patient programs. ‘enrollment,’ said Trialbee CEO Matt Walz. “Market needs have changed and traditional approaches to patient matching and enrollment have become a bottleneck in bringing new drugs, devices and therapies to patients who need them most. Trialbee Honey is a next generation solution to this industry dilemma.

Created to ensure transparency in patient recruitment and foster convenient communication and engagement, Honey’s analytics dashboard enables study teams to consolidate participants recruited from multiple sources and increase enrollment conversions .

By knowing which recruiting strategies and campaigns attract the best candidates and which sites are quick to follow, patient recruiting teams can allocate resources to the most effective channels and sites to optimize recruiting results. This includes the ability to identify the most suitable recruitment strategies and channels to deliver a more representative patient group.

The story continues

Honey’s platform is a centralized digital infrastructure for patient recruitment into clinical trials, delivering unique user experiences to patients, sites, and sponsors / CROs, all running on a common data architecture that analyzes business real-time recruitment and enrollment from all patient sources. It offers 360-degree transparency in enrollment programs, enabling adaptive patient recruitment based on real-time information.

“Trialbee Honey manages all patient matching and enrollment activities, regardless of recruiting source, in a single, purpose-built solution. The robust analytics dashboard enables transparency, streamlines recruitment processes and improves representation of diversity in trials so patient recruitment teams are empowered to make timely decisions that shorten enrollment times, ”explains Martin Kilsgard, Trialbee Product Manager.

About Trialbee
Trialbee is the world’s leading data and technology platform for patient matching and clinical trial recruitment. Trialbee Hive â„¢ operationalizes real world data (RWD) and applies data science to match patients globally. Trialbee Honey â„¢ simplifies the matched patient journey, reduces the patient registration burden for sites, and provides real-time, data-driven information to sponsors and CROs so they can optimize registration times . In partnership with sponsors, CROs, virtual / decentralized sites and software vendors, Trialbee achieves patient recruitment goals and improves the diversity of clinical trial populations. We’re the smartest way to match and enroll patients for your clinical trial. For more information visit http://www.trialbee.com or contact us at [email protected].

See the source version on businesswire.com: https://www.businesswire.com/news/home/20211026005147/en/

Contacts

Media:
Rosine Ferrante
Gregory FCA (for Trialbee)
215-344-2113
[email protected]